law.justia.com/cases/federal/appellate-courts/ca6/16-3154/16-3154-2017-10-27.html

Oct 27, 2017 ... Relators, former BMS employees, alleged in a qui tam suit that BMS and Otsuka engaged in a ... Relators allege that, despite those agreements, the companies continued to ... Ibanez v. Bristol-Myers Squibb Co., No. 16-3154 (6th Cir. 2017) ... 16-3154 U.S. ex rel. Ibanez v. Bristol-Myers Squibb, et. al. Page 2 ...

www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-1694.Opinion.2-7-2019.pdf

Feb 7, 2019 ... (all the claims) of United States Patent No. ... '239 Patent”) owned by Bristol- Myers Squibb Company ... Momenta Pharm., Inc. v. ... 311 et seq.

www.scotusblog.com/wp-content/uploads/2016/10/16-466-cert-petition.pdf

BRISTOL-MYERS SQUIBB COMPANY,. Petitioner, v. SUPERIOR COURT OF CALIFORNIA .... Nerti, Addie Newton, Julianne Nicks, Tommy W. ...... BRACY ANDERSON et al.,. Real Parties in Interest. ______. Bristol-Myers. Squibb. Company.

www.law360.com/cases/58e6506f2a2edd2f07000001

Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from  ...

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... Momenta Pharmaceuticals, Inc. v, Bristol-Myers Squibb Co. ... and covered business method patent review) against a Petitioner (loss of patent ... partes review (IPR) brought by Momenta against all claims of U.S. Patent No.

caselaw.findlaw.com/us-7th-circuit/1265038.html

WILLIAMS v. ... BRISTOL-MYERS SQUIBB COMPANY, Defendant-Appellee. ... 29 U.S.C. §§ 621 et seq., against his former employer Bristol-Myers Squibb, the ...

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.